|
WO2020227279A1
|
|
Therapy and methods of introducing immature dendritic cells and/or cytotoxic t lymphocyte and anti pd-1 / pd-l1 antibody for treatment of tumors
|
|
US2020030375A1
|
|
Therapy and methods of introducing immature dendritic cells and/or cytoxic t lymphocyte and anti pd-1 / pd-l1 antibody for treatment of tumors
|
|
US2018161367A1
|
|
Therapy and methods for introducing immature and dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumors
|
|
JP2019107298A
|
|
Puncture path setting device, puncture control amount setting device and puncture system
|
|
JP2018187171A
|
|
Registration marker and utilization program for registration marker
|
|
CN102471770A
|
|
Antigen peptide and use thereof
|
|
US2010092445A1
|
|
Adoptive immune cells for tumor vaccines
|
|
US2009074713A1
|
|
Dendritic cell tumor injection (DCTI) therapy
|
|
US2008160050A1
|
|
Dendritic cell tumor injection therapy and related vaccine
|
|
US2006216269A1
|
|
Dendritic cell tumor injection (DCTI) therapy
|
